David Bouda
Medical Oncology · Kansas City, MONPI 1912021635
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 7 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 5 manufacturers reported payments, led by AbbVie at 43.5% of the total. Reporting peaked in 2019 at $69 and has fallen 79.9% since, to $14 in 2023. That places this record below the midpoint for medical oncology clinicians in MO, where the typical reported total is $3,595.
Across 7 payments — averaging $13.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$42
- Bristol Myers Squibb$16
- Boehringer Ingelheim$14
- Amgen$12
- Merz North America, Inc.$12
Across 134 payments — averaging $9982.78 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$426K
- Noven Pharmaceuticals, Inc.$337K
- GSK$290K
- AbbVie$172K
- Chiesi USA, Inc.$67K
- Pfizer$47K
What the payments were for
- Food & beverage$96100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 3 | $42 |
| Bristol Myers Squibb | 1 | $16 |
| Boehringer Ingelheim | 1 | $14 |
| Amgen | 1 | $12 |
| Merz North America, Inc. | 1 | $12 |
How this compares
$96 in reported general payments places this provider in the 10th percentile of 144 medical oncology providers in Missouri.
Other medical oncology in Kansas City
- Timothy PluardKansas City$664K
- Shajadi PatanKansas City$8K
- Leonid ShunyakovBolivar$2.1M
- Brad KahlSaint Louis$336K
- Michael NaughtonCape Girardeau$249K
- Russell PachynskiSaint Louis$226K
- Mark SchroederSaint Louis$198K
- George AnsstasSaint Louis$189K
- Ravi VijSaint Louis$153K
- Douglas AdkinsSaint Louis$141K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.